(Q54387573)

English

Assessment of Her-2/neu status using immunocytochemistry and fluorescence in situ hybridization on fine-needle aspiration cytology smears: experience from a tertiary care centre in India.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24376261

Assessment of Her-2/neu status using immunocytochemistry and fluorescence in situ hybridization on fine-needle aspiration cytology smears: experience from a tertiary care centre in India. (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24376261

0 references

1 reference

based on heuristic

inferred from title

author name string

Prashant Durgapal

1

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24376261

Sandeep R Mathur

2

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24376261

Md Kalamuddin

3

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24376261

Siddhartha Datta Gupta

4

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24376261

Rajinder Parshad

5

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24376261

Pramod K Julka

6

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24376261

S K Panda

7

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24376261

publication date

20 December 2013

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24376261

Diagnostic Cytopathology

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24376261

42

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24376261

8

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24376261

726-731

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24376261

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FDC.23088

21 January 2018

Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification

1 reference

https://api.crossref.org/works/10.1002%2FDC.23088

21 January 2018

Current perspectives on HER2 testing: a review of national testing guidelines

1 reference

https://api.crossref.org/works/10.1002%2FDC.23088

21 January 2018

HER-2/neu amplification by fluorescence in situ hybridization in cytologic samples from distant metastatic sites of breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FDC.23088

21 January 2018

HER-2/neu gene amplification in breast imprint cytology analyzed by fluorescence in situ hybridization: direct comparison with companion tissue sections.

1 reference

https://api.crossref.org/works/10.1002%2FDC.23088

21 January 2018

Fluorescence in situ hybridisation detection of erbB2 amplification in breast cancer fine needle aspirates

1 reference

https://api.crossref.org/works/10.1002%2FDC.23088

21 January 2018

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FDC.23088

21 January 2018

Assessing HER-2 status in fresh frozen and archival cytological samples obtained by fine needle aspiration cytology.

1 reference

https://api.crossref.org/works/10.1002%2FDC.23088

21 January 2018

Detection of numerical chromosomal abnormalities by fluorescence in situ hybridization of interphase cell nuclei with chromosome-specific probes on archival cytologic samples

1 reference

https://api.crossref.org/works/10.1002%2FDC.23088

21 January 2018

Prevalence of 22q11.2 microdeletion in 146 patients with cardiac malformation in a referral hospital of North India

1 reference

https://api.crossref.org/works/10.1002%2FDC.23088

21 January 2018

Fine needle aspirate cell blocks are reliable for detection of hormone receptors and HER-2 by immunohistochemistry in breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FDC.23088

21 January 2018

Determination of the Her-2/neu gene amplification status in cytologic breast cancer specimens using automated silver-enhanced in-situ hybridization (SISH).

1 reference

https://api.crossref.org/works/10.1002%2FDC.23088

21 January 2018

c-erbB2/neu gene and chromosome 17 analysis in breast cancer by FISH on archival cytological fine-needle aspirates.

1 reference

https://api.crossref.org/works/10.1002%2FDC.23088

21 January 2018

Overexpression of HER2/neu oncoprotein in cytologic specimens

1 reference

https://api.crossref.org/works/10.1002%2FDC.23088

21 January 2018

c-erbB-2 expression in FNAB smears and matched surgical specimens of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FDC.23088

21 January 2018

Assessment of thin-layer breast aspirates for immunocytochemical evaluation of HER2 status

1 reference

https://api.crossref.org/works/10.1002%2FDC.23088

21 January 2018

Comparison of liquid based cytology and histology for the evaluation of HER-2 status using immunostaining and CISH in breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FDC.23088

21 January 2018

Hormone receptor status and HER2/neu overexpression determined by automated immunostainer on routinely fixed cytologic specimens from breast carcinoma: correlation with histologic sections determinations and diagnostic pitfalls

1 reference

https://api.crossref.org/works/10.1002%2FDC.23088

21 January 2018

Comparison of fluorescence in situ hybridization and immunohistochemistry for assessment of HER-2 status in breast cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FDC.23088

21 January 2018

Comparison of the results of immunocytochemical assays for biologic variables on preoperative fine-needle aspirates and on surgical specimens of primary breast carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FDC.23088

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorescence in situ hybridization for detecting erbB-2 amplification in breast tumor fine needle aspiration biopsies

1 reference

https://api.crossref.org/works/10.1002%2FDC.23088

7 January 2021

based on heuristic

inferred from DOI database lookup

Chromogenic In Situ Hybridization to Detect HER-2/neu Gene Amplification in Histological and ThinPrep(R)-Processed Breast Cancer Fine-Needle Aspirates: A Sensitive and Practical Method in the Trastuzumab Era

1 reference

https://api.crossref.org/works/10.1002%2FDC.23088

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunocytochemical evaluation of HER-2/neu on fine-needle aspirates from primary breast carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FDC.23088

7 January 2021

based on heuristic

inferred from DOI database lookup

Hormone receptor and human epidermal growth factor receptor 2 status evaluation on ThinPrep specimens from breast carcinoma: correlation with histologic sections determination

1 reference

https://api.crossref.org/works/10.1002%2FDC.23088

7 January 2021

based on heuristic

inferred from DOI database lookup

HER-2/neu amplification detected by fluorescence in situ hybridization in fine needle aspirates from primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FDC.23088

7 January 2021

based on heuristic

inferred from DOI database lookup

Fine-needle aspiration technique for the concurrent immunocytochemical evaluation of multiple biologic parameters in primary breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FDC.23088

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunocytochemical staining of c-erb B-2 oncogene in fine-needle aspirates of breast carcinoma: a comparison with tissue sections and other breast cancer prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2FDC.23088

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/DC.23088

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24376261

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24376261

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54387573&oldid=1500158216"